We are getting excited to once again exhibit at the ISPOR Annual Meeting to be held in Philadelphia, PA, May 18-20, 2026.
Find us at Booth # 511
- Monday 9:30 AM-7:00 PM
- Tuesday 9:30 AM-7:00 PM
- Wednesday 8:30 AM-11:30 AM
Meet the team and check out our poster presentations:
Monday, May 18
PODIUM PRESENTATION, 10:30-11:30 AM
- Real-World Effectiveness of Anti-Obesity Pharmacotherapy in Medicare: Integrated 100% Fee-For-Service Claims and EMR Analysis of BMI Reduction and Cardiovascular Outcomes
ONCOLOGY POSTER TOUR, 11:30 AM-12:15 PM
- Targeted Therapy, Immunotherapy, and Molecular Testing in Advanced Solid Tumors: A 2021–2025 Medicare Analysis (PT6)
Session 1 Discussion: 12:30-1:30 PM
- Early Identification of Postpartum Depression Risk using Artificial Intelligence (MSR7)
- Real-World Impact of Anti-Amyloid Therapy in Alzheimer’s Disease: An Integrated Analysis of 100% Medicare FFS Claims Linked with Laboratory, Electronic Medical Records, and Patient-Reported Outcomes Measures (CO21)
Session 2 Discussion: 6:00-7:00 PM
- Modeling Rare Events in Health Intervention: An Application from the Department of War Dataset (MSR69)
Tuesday, May 19
Session 3 Discussion: 12:30-1:30 PM
- Real-World Safety and Outcomes of Bispecific Antibodies in Older Adults (CO106)
- Real-World Impact of Modern Obesity Pharmacotherapy on Liver Outcomes in Medicare-Enhanced Lab and Demographics Data: 2021–2025 (CO88)
- Projected Impact of Personalized mRNA Neoantigen Cancer Vaccines in Medicare: A Scenario Analysis Using Trial Efficacy and Linked Data Population Estimates (EPH113)
- Healthcare Resource Use in Rare Disease Clinical Trials: A Systematic Review (EE277) (TOP 5% FINALIST)
Session 4 Discussion: 6:00-7:00 PM
- Laboratory Markers and Short-Term Outcomes in Respiratory Syncytial Virus Among Older Adults: Medicare-Enhanced and Laboratory Data Analysis 2021–2025 (CO153)
- Real-World Multiple Myeloma Treatment Responses: Evaluation of Frontline Regimens in MELDTM Linked Medicare, Laboratory and Electronic Medical Records (CO144)
- Prevalence and Incidence of Obesity and Budget Impact of the MOVE! Weight Management Program in US Veterans (EPH143)
- Real-World Perioperative Immunotherapy and Cellular Therapy in Older Adults with Solid Tumors: A 2021–2025 Medicare-EMR Linked Analysis (CO143) (TOP 5% FINALIST)
Wednesday, May 20
Session 5 Discussion: 9:00-10:00 AM
- Comparative Risk of Suicidal Ideation and Self-Harm Among Patients with Major Depressive Disorder Treated with Brexpiprazole versus Other Oral Atypical Antipsychotics: A Propensity Score–Matched Cohort Analysis (CO175)
- Inflation Reduction Act “Pill Penalty” and Small-Molecule Innovation: Signals from Investment, Pipelines, and Post-Approval Research (HPR139)
- Timing of Serious Adverse Events Following Mifepristone Abortion in US Commercial and Medicaid Populations (CO189)
- Treatment Patterns and Gaps in Resectable Mucosal Melanoma Care for Medicare Beneficiaries in the United States (CO186)
Learn more about ISPOR.
Find more CDA presentations and publications here.
